This grant is for strengthening endemic countries’ program capacity to eliminate lymphatic filariasis (LF) and control other neglected tropical diseases (NTDs). The Division of Parasitic Diseases and Malaria (DPDM) at CDC aims to support achieving mass drug administration (MDA) coverage targets, establishing robust surveillance systems for recrudescence, and developing prompt responses to persistent transmission. It also supports integrating NTD services within national health systems. This initiative seeks to improve the quality, access, and participation in MDA campaigns, enhance chronic disease management, and ensure high-quality monitoring, evaluation, and post-elimination surveillance for diseases like LF, onchocerciasis, trachoma, and soil-transmitted helminths. This funding supports non-research activities to reduce the global burden of NTDs.
Opportunity ID: 327713
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2104 |
| Funding Opportunity Title: | Elimination of lymphatic filariasis and elimination and control of other neglected tropical diseases (NTDs) in an effort to improve the quality and coverage of local programs. |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.084 — Prevention of Disease, Disability, and Death by Infectious Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 18, 2020 |
| Last Updated Date: | Dec 18, 2020 |
| Original Closing Date for Applications: | Feb 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Feb 19, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 21, 2021 |
| Estimated Total Program Funding: | $3,450,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | County governments Special district governments Independent school districts Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Private institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | This is an open competition NOFO |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | Globally, neglected tropical diseases (NTDs) affect more than one billion people, primarily in the worlds poorest nations. CDC, together with other U.S. government and global partners, is supporting elimination/control of six NTDs (lymphatic filariasis, onchocerciasis, trachoma, soil-transmitted helminths, schistosomiasis, Guinea worm) through community mass drug administration (MDA), water filters, or other tool-ready public health interventions such as vector control or improved water, sanitation and hygiene (WASH). Among these, lymphatic filariasis (LF), a mosquito-borne disease that can lead to permanent disability from elephantiasis or hydrocele, was targeted for elimination by 2020. Although the global target was not met, 16 countries have eliminated LF as a public health problem, and many others are close to achieving elimination. Achieving global targets is challenging in many settings, such as highly urban areas. Control of LF usually depends on provision of antiparasitic drugs through MDA with high (>65%) community coverage for at least five years in order break the cycle of transmission. Locally relevant strategies ensuring sufficiently high MDA community coverage and low levels of systematic non-compliance are needed. New data support that addition of a third drug, ivermectin, in some settings to the traditional dual drug (dethylcarbamazine [DEC] plus albendazole) regimen can shorten the number of annual MDAs required for LF elimination if high community MDA coverage is achieved. After reaching MDA targets, country programs must develop feasible and sustainable surveillance systems able to identify LF recrudescence, as well as processes that effectively manage areas of persistent transmission in order to limit LF spread. Other NTDs have potential to be eradicated (Guinea worm), eliminated (onchocerciasis, trachoma) or controlled (schistosomiasis, soil transmitted helminths) through well-conducted quality community campaigns over a sustained period. The Division of Parasitic Diseases and Malaria (DPDM) at the Centers for Disease Control and Prevention (CDC) has provided technical assistance on NTD elimination/control for national programs in Africa, the Americas, Asia and the Pacific over many decades, working closely with the World Health Organization (WHO) and national health ministries. The purpose of this announcement is to support endemic countries in strengthening their program capacity for elimination/control of LF and other NTDs through achieving MDA coverage targets; establishing ongoing, systematic surveillance systems that can identify recrudescence of infection; establishing standard procedures for responding promptly to persistent or recrudescent transmission; and supporting integrated health services for LF and other NTDs within national health systems. For LF, measurable outcomes of the program will be: improved quality of, access to, and participation in MDA campaigns; better understanding of community participation (and non-participation) in MDAs by countries and other stakeholders; improved management of chronic disease in communities; identification of appropriate MDA stopping points and hotspot management; and establishment of feasible yet high-quality monitoring, evaluation and surveillance before, during and after MDAs. For other NTDs, measurable outcomes will be improved quality of MDAs; understanding of MDA starting and stopping points (e.g., onchocerciasis); high quality conduct of NTD monitoring, evaluation and surveillance, including post-elimination surveillance; and integration of NTD surveillance and services within existing health systems. This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be reviewed. For the definition of research, please see the CDC Web site at the following Internet address: http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Robin Nilson
jnilson@cdc.gov Email:jnilson@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 327713 Full Announcement-FULL_ANNOUNCEMENT -> CDC-RFA-GH21-2104.pdf
Packages
| Agency Contact Information: | Robin Nilson jnilson@cdc.gov Email: jnilson@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.084 | CDC-RFA-GH21-2104 | Elimination of lymphatic filariasis and elimination and control of other neglected tropical diseases (NTDs) in an effort to improve the quality and coverage of local programs. | PKG00264553 | Dec 17, 2020 | Feb 19, 2021 | View |
Package 1
Mandatory forms
327713 SF424_3_0-3.0.pdf
327713 Project_AbstractSummary_2_0-2.0.pdf
327713 SFLLL_2_0-2.0.pdf
327713 SF424A-1.0.pdf
327713 BudgetNarrativeAttachments_1_2-1.2.pdf
327713 ProjectNarrativeAttachments_1_2-1.2.pdf
327713 HHS_CheckList_4_0-4.0.pdf
Optional forms
327713 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
